Caprolactam supplier Fibrant is winding down its US operations. The company, which was sold off by Netherlands firm DSM, will close its production site in Augusta, Georgia, with the loss of several hundred jobs.
The company said the closure was the ‘only viable course of action’ in the face of extended unfavourable market conditions caused by poor commodity chemical prices, as well as ‘global supply and demand dynamics’.
Fibrant will continue to produce caprolactam for nylon manufacture in the Netherlands and China. The company employs around 1200 staff across the three continents.
By Phillip Broadwith
Source: Chemistry World
Saudi Industrial Investment Group (SIIG; Riyadh) and National Petrochemical Co. (Petrochem; Jubail, Saudi Arabia) say they have started talks over a potential merger of the two companies. SIIG and Petrochem […]
Solvay has launched its Peroxides for the Future (P4F) program, a multi-year plan to adapt its peroxides industrial footprint in EMEA and make product available where customers need it most. […]
INEOS Styrolution and Trinseo, global leaders in the manufacturing of polystyrene and other styrenic materials, announced today that they are advancing plans to build the first-of-its-kind polystyrene recycling plant based […]
